Immunisation Update: Recording of Prevenar 13 as the 4th dose

The ACIR reporting requirements in relation to the Prevenar 13 supplementary dose for children aged 12 to 35 months of age.

The Prevenar 13 supplementary dose should be reported to the ACIR as dose 4 to enable accurate reporting against the catch up program. For children who are on a catch up schedule for their primary course of pneumococcal vaccination (ie. they may have received less than 3 doses), if they are eligible for the supplementary program, the supplementary dose still needs to be recorded as dose 4 on the ACIR.

Reporting of Prevenar 13 dose 4 can be submitted to the ACIR manually in the 'Other vaccine' box on the Immunisation Encounter (IMMU-2) form.
Providers using the Record Encounter function on the ACIR secure internet site can report dose 4 of Prevenar 13 under the 'Other' tab. Other electronic methods of reporting data to the ACIR (Online Claiming and Internet Data Interchange (IDI)) should now be set up to submit Prevenar 13 dose 4 details to the ACIR.

• « Previous article
• Next article »